Pieris Pharmaceuticals Stock Technical Analysis

PIRSDelisted Stock  USD 13.60  1.41  9.39%   
As of the 19th of December, Pieris Pharmaceuticals holds the Variance of 7.53, risk adjusted performance of (0.08), and Coefficient Of Variation of (911.59). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pieris Pharmaceuticals, as well as the relationship between them. Please check Pieris Pharmaceuticals coefficient of variation and value at risk to decide if Pieris Pharmaceuticals is priced some-what accurately, providing market reflects its current price of 13.6 per share. Given that Pieris Pharmaceuticals has information ratio of (0.12), we recommend you to check out Pieris Pharmaceuticals's recent market performance to make sure the company can sustain itself at a future point.

Pieris Pharmaceuticals Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Pieris, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Pieris
  
Pieris Pharmaceuticals' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Pieris Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Pieris Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Pieris Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Pieris Pharmaceuticals Technical Analysis

Indicator
Time Period
Execute Indicator
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Pieris Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Pieris Pharmaceuticals Trend Analysis

Use this graph to draw trend lines for Pieris Pharmaceuticals. You can use it to identify possible trend reversals for Pieris Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Pieris Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Pieris Pharmaceuticals Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Pieris Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of   0.01  , which may suggest that Pieris Pharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 6.26, which is the sum of squared deviations for the predicted Pieris Pharmaceuticals price change compared to its average price change.

About Pieris Pharmaceuticals Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Pieris Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Pieris Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Pieris Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Pieris Pharmaceuticals. By analyzing Pieris Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Pieris Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Pieris Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.

Pieris Pharmaceuticals December 19, 2024 Technical Indicators

Most technical analysis of Pieris help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Pieris from various momentum indicators to cycle indicators. When you analyze Pieris charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pieris Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Consideration for investing in Pieris Stock

If you are still planning to invest in Pieris Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pieris Pharmaceuticals' history and understand the potential risks before investing.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
CEOs Directory
Screen CEOs from public companies around the world
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios